🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr Laurie Sehn FL : next questions? Currently available to options #SOHO2024 Women in Lymphoma - [email protected]

Dr A Moskowitz HL : next questions Optimal salvage tx? #SOHO2024 Women in Lymphoma - [email protected]

👏Dr G Manero G Garcia-Manero for an incredible meeting !#SOHO2024 #soho24

We are thrilled to welcome Michel Sadelain, MD, PhD, a global pioneer in CAR-T therapies, to Columbia and the HICCC.

Super proud of our super⭐️ Dr Yiran Emily Peng for receiving the Physician Partner of the Year award ! 👏👏👏NewYork-Presbyterian Herbert Irving Comprehensive Cancer Center

New SOC in Adv stage HL

🙏 great meeting you!

NEXT WEEK: Join us for ‘Recent Advances in the Diagnosis & Treatment of AL #Amyloidosis’ - a virtual conference on November 1, 2024 hosted by Columbia University, Department of Medicine. Info & registration: eventleaf.com/e/Amyloidosis2… #NephTwitter #NephX #nephrology #cardiology

At the NY cutaneous lymphoma consortium grand rounds chaired by Dr L Geskin 🎃 version! Looking forward to a great program Herbert Irving Comprehensive Cancer Center Columbia Medicine

Dr R Reshef Herbert Irving Comprehensive Cancer Center Columbia Medicine presenting the potential of CAR T cell therapy in CTCL

Register for SOHO State of the Art Updates and Next Questions DON'T MISS this one-day event!  Join us virtually on November 22, 2024, to hear Hagop Kantarjian,MD, G Garcia-Manero, Barbara Pro, calliecoombs, Sagar Lonial MD as they tackle the most pressing questions!

🩸🧬Happy to share this Foresight Diagnostics Inc. release ahead of #ASH24 on our MRD-guided study for newly diagnosed DLBCL is now open at Herbert Irving Comprehensive Cancer Center! The overall goal is to de-escalate cytotoxic chemotherapy for early molecular responders #lymsm #mrd clinicaltrials.gov/study/NCT06693…

Unlocking the potential of epigenetic therapies! Seda Tolu and colleagues explore the promise of combining epigenetic agents with other treatments to enhance outcomes in NatureRevClinOncol oncodaily.com/url/197882 Aaron Viny Jennifer Amengual Barbara Pro Susan Bates #Cancer

Combination JAK inhibition and Immune checkpoint blockade being presented by Seda Tolu 👏 Herbert Irving Comprehensive Cancer Center #ASH2024 #ASH24

Sunday 🦅 mood 🏈 #GoBirds

Start spreadin’ the news… we’re headed to New York for the 9th Annual Live Medical Crossfire®: Hematologic Malignancies! Join Barbara Pro Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Amer Zeidan MBBS,MHS ‏عامر زيدان for expert-led debates and real-time insights! 🗽Get 75% off HCP registration with code MXH75 bit.ly/4jIw2wE

🗽 Big debates. Bold insights. Live in New York. Join us for the 9th Annual #MXH25 — a one-day, fast-paced event where experts tackle today’s most pressing challenges in hematologic cancer. HCPs save 75% with code MXH75: bit.ly/4jIw2wE Barbara Pro Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Amer Zeidan MBBS,MHS ‏عامر زيدان pic.x.com/vZoxzWPvuA

Goals of CML frontline therapy Hagop Kantarjian,MD #ThinkTank2025

Suzanne Lentzsch receives the CoMy award for women’s achievement in MM very deserved and supported by her family and work colleagues

Results from 4 pivotal phase 3 trials (MIDAS, PERSEUS, IsKIA, ADVANCE) representing current thinking on the role of ASCT in NDMM, masterfully summarized and contextualized by Suzanne Lentzsch, MD, PhD! #ASCO25 #MYELOMA #MRD Herbert Irving Comprehensive Cancer Center